GGrantIndex
← Search

DEVELOPMENT OF ANTIBODY THERAPY AGAINST IMMUNOSUPPRESSIVE CELLS IN BLOOD CANCER PATIENTS

$576,001FY2015Department of DefenseDOD

Beckman Research Institute Of The City Of Hope

Investigators

View source on USAspending →
DEVELOPMENT OF ANTIBODY THERAPY AGAINST IMMUNOSUPPRESSIVE CELLS IN BLOOD CANCER PATIENTS · GrantIndex